Last updated on December 2019

The PARTNER 3 - AVIV Trial

Brief description of study

To assess the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve in patients with a failing aortic bioprosthetic valve.

Detailed Study Description

A prospective, single-arm, multicenter clinical trial. The trial will enroll patients with a failing surgical or transcatheter bioprosthetic valve in the aortic position demonstrating stenosis and/or insufficiency.

Clinical Study Identifier: NCT03003299

Find a site near you

Start Over

Lankenau Medical Center

Wynnewood, PA United States
  Connect »

University of Pennsylvania Hospital

Philadelphia, PA United States
  Connect »